---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-001841"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:15:05.989454+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Lipocine updates corporate investor presentation; no specific changes disclosed

## Summary
- Filed updated corporate presentation as Exhibit 99.1 used with investors and analysts.
- No financial data, milestones, or guidance changes included in the 8-K text.
- Presentation content not provided in the filing excerpt; materiality cannot be assessed.
- Ticker LPCN; common stock listed on Nasdaq.

## SEC filing metadata
- accession: 0001493152-25-001841
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315225001841/0001493152-25-001841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315225001841/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-001841
- JSON: https://secwatch.observer/filing/0001493152-25-001841.json
- Plain text: https://secwatch.observer/filing/0001493152-25-001841.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.